|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
52,907,000 |
Market
Cap: |
N/A |
Last
Volume: |
678,324 |
Avg
Vol: |
306,439 |
52
Week Range: |
$11.15 - $11.15 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cavazza Paolo |
10% Owner |
|
2008-01-15 |
4 |
B |
$2.01 |
$102,579 |
I/I |
50,976 |
6,474,365 |
1.5 |
- |
|
Cavazza Claudio |
10% Owner |
|
2008-01-15 |
4 |
B |
$2.01 |
$102,579 |
I/I |
50,976 |
6,474,365 |
1.5 |
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2008-01-14 |
4/A |
B |
$2.00 |
$400 |
I/I |
200 |
6,423,189 |
1.42 |
- |
|
Cavazza Claudio |
10% Owner |
|
2008-01-14 |
4/A |
B |
$2.00 |
$400 |
I/I |
200 |
6,423,189 |
1.42 |
- |
|
Cavazza Paolo |
10% Owner |
|
2008-01-14 |
4/A |
B |
$2.00 |
$400 |
I/I |
200 |
6,423,189 |
1.42 |
- |
|
Cavazza Claudio |
10% Owner |
|
2008-01-14 |
4 |
B |
$2.00 |
$800 |
I/I |
400 |
6,423,389 |
1.42 |
- |
|
Cavazza Paolo |
10% Owner |
|
2008-01-14 |
4 |
B |
$2.00 |
$800 |
I/I |
400 |
6,423,389 |
1.42 |
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2008-01-14 |
4 |
B |
$2.00 |
$800 |
I/I |
400 |
6,423,389 |
1.42 |
- |
|
Cavazza Claudio |
10% Owner |
|
2008-01-11 |
4 |
B |
$2.00 |
$55,982 |
I/I |
28,001 |
6,422,989 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2008-01-11 |
4 |
B |
$2.00 |
$55,982 |
I/I |
28,001 |
6,422,989 |
1.5 |
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2008-01-11 |
4 |
B |
$2.00 |
$55,982 |
I/I |
28,001 |
6,422,989 |
1.5 |
- |
|
Henel Rolf H |
Director |
|
2007-12-31 |
4 |
S |
$2.03 |
$19,509 |
D/D |
(9,400) |
10,600 |
|
- |
|
Henel Rolf H |
Director |
|
2007-12-28 |
4 |
B |
$2.26 |
$21,336 |
D/D |
9,400 |
20,000 |
2.39 |
- |
|
Schmid Hans P |
Pres & Mng Dir, SciClone Intl |
|
2007-12-14 |
4 |
B |
$2.33 |
$10,459 |
D/D |
4,489 |
51,136 |
2.74 |
- |
|
Henel Rolf H |
Director |
|
2007-11-23 |
4 |
B |
$1.85 |
$925 |
D/D |
500 |
10,600 |
2.31 |
- |
|
Saxe Jon S |
Director |
|
2007-11-21 |
4 |
B |
$1.87 |
$9,456 |
D/D |
5,000 |
15,000 |
2.39 |
- |
|
Henel Rolf H |
Director |
|
2007-11-20 |
4 |
B |
$1.81 |
$181 |
D/D |
100 |
10,100 |
2.31 |
- |
|
Saxe Jon S |
Director |
|
2007-11-20 |
4 |
B |
$1.88 |
$18,980 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
Blobel Friedhelm |
President & CEO |
|
2007-11-20 |
4 |
B |
$1.93 |
$9,640 |
D/D |
5,000 |
5,000 |
2.81 |
- |
|
Woodman Dean S |
Director |
|
2007-11-19 |
4 |
B |
$1.96 |
$17,640 |
D/D |
9,000 |
70,000 |
2.39 |
- |
|
Woodman Dean S |
Director |
|
2007-11-16 |
4 |
B |
$2.01 |
$50,345 |
D/D |
25,000 |
61,000 |
2.39 |
- |
|
Woodman Dean S |
Director |
|
2007-11-15 |
4 |
B |
$2.00 |
$31,971 |
D/D |
16,000 |
36,000 |
2.39 |
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2007-11-13 |
4 |
B |
$2.04 |
$111,575 |
I/I |
54,640 |
6,394,988 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2007-11-13 |
4 |
B |
$2.04 |
$111,575 |
I/I |
54,640 |
6,394,988 |
1.5 |
- |
|
Cavazza Claudio |
10% Owner |
|
2007-11-13 |
4 |
B |
$2.04 |
$111,575 |
I/I |
54,640 |
6,394,988 |
1.5 |
- |
|
565 Records found
|
|
Page 15 of 23 |
|
|